Capricor Therapeutics, Inc. (CAPR)
27.78
-0.78
(-2.73%)
USD |
NASDAQ |
Dec 09, 12:27
Capricor Therapeutics Shareholders Equity (Quarterly): 83.87M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 505.82M |
| Inovio Pharmaceuticals, Inc. | -7.72M |
| Perspective Therapeutics, Inc. | 242.22M |
| Arcturus Therapeutics Holdings, Inc. | 224.56M |
| Myomo, Inc. | 14.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.44M |
| Total Liabilities (Quarterly) | 42.57M |
| Debt to Equity Ratio | 0.2137 |
| Current Ratio | 3.586 |
| Net Debt Paydown Yield | -0.77% |